John Temperato - Feb 21, 2022 Form 4 Insider Report for 9 METERS BIOPHARMA, INC. (NMTR)

Role
Chief Executive Officer, Director
Signature
/s/ Bethany Sensenig, as power of attorney
Stock symbol
NMTR
Transactions as of
Feb 21, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 03:15 PM
Previous filing
Nov 19, 2021
Next filing
Mar 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NMTR Stock Option (Right to Buy) Award $0 +2.48M $0.00 2.48M Feb 21, 2022 Common stock 2.48M $0.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of these shares shall be deemed vested and exercisable on February 21, 2023 with the remainder vesting in equal monthly installments over the next 36 months, such that the option shall be fully vested on February 21, 2026, subject to the executive's continued service with the Company through each applicable vesting date.

Remarks:

EX-24: Power of Attorney